Daniel Loeb started to build up the position in Neurocrine Biosciences in Q4 2006 and continued to invest until Q1 2007. Since then they sold 1.22M shares. The investor sold all their shares in Q2 2007 and doesn't own any shares in Neurocrine Biosciences anymore.